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Foreword 
 
The present paper is a summary of four independent studies:  
 literature research1 on the decentralisation models and experiences in the resource-
limited African context 
 study of perception of different stakeholders2: MSF, health care staff, national 
authorities, international actors, patients and the wider community 
 description of the decentralisation model of Shiselweni region and analysis of the 
programme outcomes in wider public health context3  
 cost-effectiveness analysis4 of HIV service provision in primary health care clinics (PHCC) 
versus secondary health care facilities (SHCF) 
Two additional papers that have contributed to this paper include the infection control 
report5 about new construction and rehabilitation works as well as the laboratory 
improvement report6 on innovative diagnostic methods. 
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Executive summary 
The example of Shishelweni demonstrates that in the context of high prevalence of HIV/TB 
infections and limited resources available decentralisation of HIV and TB care from regional 
and district hospitals to primary health care clinics and community level is the way to 
improve access, coverage, effectiveness and efficiency of service delivery. It also improves 
satisfaction and acceptance of health service providers, direct beneficiaries and the wider 
community.  
The key to a successful decentralisation is the improved capacity of human resources for 
health, with a strong and well implemented task-shifting component. Inclusion of lay 
people and namely people living with HIV/AIDS and TB in the service provision through 
task-shifting improves the acceptance of medical services by the affected population. It 
also decreases stigma as a principle access barrier and improves the self-esteem and 
recognition of the affected populations in the community. Intensification of infection 
control measures and adaptation of laboratory services to the needs of expanded health 
care were instrumental to the Shiselweni model of decentralisation.  
Decentralisation of activities at primary health care clinic and community levels has greatly 
increased access to the diagnostic and curative services for HIV and TB patients. The 
proportion of people accessing the antiretroviral treatment (from those in need of it) 
reached ‘universal’ coverage7 in 2012 (versus baseline ART coverage of 17% in 2006). 
Increased access was intertwined with improvement of treatment effectiveness over time. 
Antiretroviral treatment outcomes of annual cohorts at regional level have constantly 
improved at every follow-up interval (12, 18 and 24 months) with a tendency of the 
primary health care clinics to show better survival indicators as compared to the secondary 
health care facilities. TB treatment workload has shifted to the primary health care clinics 
and showed a clear trend of better treatment outcomes among all drug-sensitive TB 
patients at both health care levels. Less defined was an improvement in drug-resistant TB 
treatment outcomes though. Decreasing burden of TB and other HIV-related opportunistic 
infections (the main health hazard for the country’s population) correlates well in time 
with the reduction of crude mortality in Shiselweni from 2008 to 2012.  
Decentralisation is also highly cost-effective from the service provider perspective and 
allows a better use of resources than at a central level only. However, this study conforms 
to the earlier findings that decentralisation and task-shifting is not the means to save 
money but rather an opportunity to invest money in the health of the population with 
better outcomes. 
In conclusion, decentralised health care with task shifting in Shiselweni has strengthened 
human resources for health, empowered PLWHA and the wider community. It resulted in 
improved access and better direct treatment outcomes. Through lowered burden of the 
opportunistic infections it might have contributed to the overall reduction of mortality in 
the region. Decentralization is an efficient way of using scarce resources; therefore it 
requires strong commitment from all stakeholders, in terms of adequate policies, practices 
and effective funding mechanisms.  
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Abbreviations 
 
ART antiretroviral treatment 
ARV/s antiretroviral drug/s 
CTC community testing counsellors  
CTS community treatment supporters 
DR-TB drug-resistant tuberculosis 
DST drug sensitivity test  
DS-TB drug-sensitive tuberculosis 
GDP gross domestic product 
HRH human resources for health  
HTC HIV testing counsellors 
ICER incremental cost-effectiveness ratio 
MDR-TB multidrug-resistant tuberculosis 
MoH Ministry of Health 
MSF Médecins Sans Frontières 
MSF-CH  Médecins Sans Frontières Switzerland  
MTB mycobacterium tuberculosis 
NGO non-governmental organisation 
NTSF National Task-Shifting Framework 
OCG Operational Centre Geneva 
OI opportunistic infection/s 
PHCC primary health care clinics  
PIMA CD4 point-of-care machine 
PLWHA people living with HIV and AIDS 
PMTCT B+ prevention of mother-to-child transmission (WHO regimen with ART for 
all HIV-positive women) 
PMTCT prevention of mother-to-child transmission 
POC point-of-care 
PSEC patient support education and communication  
SHCF  secondary health care facility/ies  
VCT voluntary counselling and testing 
XDR-TB extremely drug-resistant tuberculosis 
Xpert®MTB/RIF GeneXpert®MTB/RIF assay 
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1 Introduction 
 
1.1 Background 
The rise of the HIV/TB burden and the demand for equity of care require a scaling-up of the 
provision of HIV and TB services to decentralised care at grass root levels worldwide.8 
Today, evidence emerges that antiretroviral treatment (ART) not only saves lives and 
alleviates suffering but also works as prevention and can slow down the epidemic.  
The decentralisation concept has been used to deliver HIV care, subsequently broadened 
to HIV/TB care as co-epidemic diseases, to increase the scaling-up, coverage and impact 
especially in resource-limited settings.9 The problems behind the concept of 
decentralisation have also been realised, such as increased demand for already limited 
resources (e.g. quantity and quality of human resources, laboratory capacity), financial 
burden and lack of accountability, lack of community participation, political conflict 
between different levels of organisations as well as sustainability.10 
 
1.2 MSF in Shiselweni, Swaziland 
Five years after the initiation of an HIV/TB decentralisation and integration project in 
Swaziland, MSF Switzerland (MSF-CH) took the opportunity to retrospectively analyse its 
programme experience and data to explain lessons learned, including successes and 
failures, to the entire MSF movement, national authorities and international community. 
Swaziland, with a population of 1.018 million people, is a small, mountainous country 
landlocked by South Africa and Mozambique and one of three monarchies in Africa. 
Despite its status as one of the ’healthier’ countries in sub-Saharan Africa, the kingdom is 
only in 142nd place according to the human development index11 of 2009 and an estimated 
81% of the population live on less than US$2 per day. The economy is highly dependent on 
that of South Africa and since the end of the 1990s economic growth has decreased to less 
than 0.4% in 2009.12 The country has the highest HIV prevalence among adults aged 15 to 
49 years worldwide. It reached about 26% in 2004 and levelled off there.13 Swaziland also 
has one of the highest tuberculosis incidence rates estimated at 1198 TB 
cases/100 000/year.14 The co-epidemic has substantially contributed to a halving of life 
expectancy within two decades – from 60 years in the 1990s to 31 in 2007.15 
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After a four-month assessment, MSF-CH signed a memorandum of understanding with the 
Ministry of Health and Social Welfare in November 2007 to start providing HIV and TB care, 
including drug-resistant tuberculosis (DR-TB), throughout Shiselweni region of Swaziland. 
The region was considered as the poorest and most remote part of the country, challenged 
among others by poor health infrastructure and overall health outcomes.  
According to the assessment, the following factors that needed to be countered 
immediately were identified: chronic staff shortages, absence of integration of HIV/TB 
services, largely centralised service and an inadequate capacity to provide HIV/TB care at 
primary clinics. Given the mountainous landscape, scattered populations and high 
transport costs, care was in practice inaccessible for the majority of Swazis living in rural 
areas. 
Figure 1: map of Shiselweni region, Swaziland 
 
1.3 Methodology 
Beginning of 2012, the Vienna Evaluation Unit was commissioned with the task to conduct 
a comprehensive evaluation of the MSF-CH project in Swaziland. The main objective was to 
evaluate appropriateness, effectiveness and efficiency of a decentralisation model of 
HIV/AIDS & TB care in the period from 2008 to 2012.16  
The purpose of the evaluation is  
 to capitalise on the experience within MSF in order to inform similar projects elsewhere,  
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 to share the experience with MSF partners in Swaziland and possibly promote its 
replication in the country and 
 to share the experience of MSF/MoH widely through publication/s. 
Given the large scale of the overall evaluation as well as the challenges faced by the data 
collection and monitoring systems, the evaluation was conducted stepwise. The following 
works were instrumental to this report.  
1. The main objective of the literature review was to explore the processes of HIV/TB 
decentralisation17 in Africa by understanding different strategies in various countries, 
the challenges they face and the consequences to which they have led, and the role of 
task shifting in decentralisation. The review also aimed to assess the future perspectives 
of HIV/TB care and decentralisation in the resource-poor context. It reviewed 98 
published papers and used the methodology of purposeful sampling.  
2. The report on the decentralisation model of Shiselweni and its outcomes combines two 
parts. The main objectives were 1) to describe the strategies and activities employed by 
the HIV/TB decentralisation model of Shiselweni with a special focus on human 
resources for health (HRH) and task shifting; 2) to analyse and show health outcomes of 
the beneficiaries of the programme in wider public health perspective. The 
methodology is based on a project-related document review, the interviews and an 
analysis of routinely collected individual patient data.  
3. The main objective of the perception study was to comprehend the acceptance of the 
HIV/TB decentralised programme in Shiselweni by all key stakeholders who had been 
involved in delivering health care or were benefiting from it. A detailed protocol was 
developed and approved by the ethics review boards of Swaziland and MSF. A total of 
118 interview sessions were conducted.  
4. The main objective of the cost-effectiveness study was to measure the cost-
effectiveness of a decentralised approach (at PHCC level) versus a centralised approach 
(at SHCF level) in the Shiselweni region of Swaziland. Investigators employed a service-
provider perspective of cost-analysis to answer the study question. Only patients on ART 
from Nhlangano zone were included. The estimates for both cost and effectiveness are 
based on a retrospective study of data routinely collected by the MoH and MSF.  
The two additional reports responding to the ToR, laboratory report and infrastructure 
report, were compiled in the people who worked hands-on in implementing the innovative 
approaches.  
The precise methodologies of the different elements are described in the respective 
reports.  
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2 Findings 
 
2.1 Decentralisation model implemented in Shiselweni 
In the resource-limited setting of Shiselweni region in Swaziland MSF-CH employed the 
following main strategies in order to achieve the goals of decentralised and integrated 
HIV/TB care:  
 Pushing for decentralised services at the PHCC and community level and their 
integration with primary health care 
 Strengthening human resources for health by ensuring effective task shifting to lower 
cadres and involving people living with HIV/AIDS (PLWHA) in service provision 
 Bringing integrated HIV and TB services closer to people at primary health care clinics 
and community levels 
 Ensuring point-of-care laboratory services 
 Improving infrastructure and patient-flow to accommodate increased workload and 
effective infection control measures  
This is quite a comprehensive approach which comprises the main priority lines 
contributing to the successful decentralisation practice as identified in the literature.  
 
The particular strengths of Shiselweni model, as perceived and suggested by different 
stakeholders in 2012, are listed below and may be interesting for replication in Swaziland:  
 Nurse-led ART and TB care at all health facilities  
 Well-organised task shifting to new cadres 
 Strong patient support, education and counselling by expert clients 
 Strong HIV and TB integration with a relevant focus on (MDR) TB 
 Decentralisation of laboratories by installing mini-laboratories at clinics and ensuring 
sample transportation to upgraded reference laboratories 
The HIV/TB care decentralisation strategies in Africa have been shaped by the following 
conditions (Kurniasari and Turashvili 2012): 
1. The level of decentralised ART initiation and management 
2. Supportive country policy and practice 
3. Human resources for health and implementation of task shifting 
4. Integration of HIV and TB care into existing health services 
5. Adaptation of ART protocols and laboratory testing strategies 
6. Optimisation of organisation of treatment and care 
Decentralisation of HIV/TB care in Shiselweni, Swaziland, summary report, 2013 
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 Piloting of innovations and operational research 
 Community component, ensuring the link between health facilities and the community 
 
2.2 The degree of decentralisation determines access 
Due to the concerted efforts of MSF-CH and the regional and central authorities, 
impressive results have been achieved at the end of the five-year period of the HIV/TB 
decentralisation programme. Treatment and care for HIV/AIDS and drug-sensitive 
tuberculosis (DS-TB) are fully decentralised to 22 primary health care clinics of the region. 
These two programmes are integrated with other departments of the primary care, 
guaranteeing a provision of so needed ‘point of care services’ for patients. Most of the HIV 
and TB services are available at community level, except ART provision. Access to DR-TB 
diagnosis and treatment in the region has dramatically increased by implementation of 
improved diagnostic technologies, such as Xpert®MTB/RIF and decentralisation of care at 
clinic and community levels.  
Figure 2: level of decentralisation linked to access to health care 
 
 
Another improvement in DR-TB treatment is linked to the construction of a new DR-TB 
ward in Nhlangano. Laboratory care is fully decentralised and integrated into the clinics via 
mini-labs and sample-transport system. Continuity in drug and medical supply is achieved 
and the medical facilities are equipped with adequate ventilation, space and waste 
management systems. Also, evidence documented in the literature clearly supports the 
need of well-implemented decentralised programmes of HIV/TB.  
 
2.3 Human resources for health and task-shifting 
The allocation of additional medical professional cadres was not adjusted to the increased 
workload. Well-designed and implemented task-shifting to the nurses and newly created 
lay cadres was instrumental to the successful implantation of the decentralisation.  
Community 
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Figure 3: access to ART is highly dependent on adjusted human resources for health 
 
 
At the beginning of decentralisation, task shifting started in Shiselweni in a step-by-step 
approach. As of today, MSF eventually implemented three levels of task shifting to 
decentralise HIV/TB care from SHCF down to the 22 PHCC of Shiselweni region (among 
them 18 MoH clinics): 
1. From doctors to nurses 
2. From nurses to lay people (mainly PLWHA) 
3. From nurses to community members, i.e.  
community treatment supporters (CTS) and PLWHA 
 
Tasks that were shifted from doctors to nurses first 
include ART refill and patient follow-up, then TB and ART 
initiation, DS-TB management and OI management 
(integrated management of adolescent and adult illness, 
WHO training course IMAI). Today, all the nurses have 
skills to fully manage ART and DS-TB at PHCC level.  
 
With the arrival of the HIV/TB epidemic, the clinic nurses found themselves to be 
overloaded and inadequately equipped to effectively support patients in their roles. Task 
shifting from nurses to lay people was organised. Expat clients were deployed first in the 
clinics and later in the community. Eventually, tasks from nurses were successfully shifted 
to the following cadres: expert clients, phlebotomists, pharmacy assistants and CTS. People 
PLWHA were given a priority in the selection of lay cadres in order to guarantee their 
empowerment, proximity to the community and reduction of stigma. 
Informal and on-the-job trainings in Shiselweni have enabled an early kick-off of the task 
shifting among different layers of cadres. However, formal training and accreditation 
proved to be equally important for an official recognition by the MoH and a future 
absorption of these cadres. Supportive supervision methods, mostly implemented by MSF 
Improved access to ART 
Human 
resources 
Human 
resources 
Human 
resources 
Decentralisation of HIV/TB care in Shiselweni, Swaziland, summary report, 2013 
9 
have been identified as adequate and effective; however more inclusion of the MoH staff 
in the supervisory teams was indicated as highly desired.  
 
2.3.1 Task-shifting policy in Swaziland 
Task shifting is now widely accepted as feasible and indispensable for the decentralisation 
of HIV/TB care in Swaziland, a country with limited human resources for health. Initial 
resistance was overcome by demonstration of its feasibility and impact. Advocacy from 
MSF side in alliance with other implementing partners was instrumental in the lobbying 
process. This led to the development of the National Task-Shifting Framework (NTSF), a 
crucial policy document for the country of Swaziland. This document reflects newly 
acquainted roles and tasks of health cadres but is still waiting for its official endorsement. 
 
2.4 Laboratory innovations 
MSF implemented innovative diagnostic 
approaches to capacitate the primary health 
care clinics with point-of-care laboratory 
technologies on the one hand, and on the other 
hand it has created the capacity of a regional 
referral laboratory in Nhlanagano.  
From 2010 onwards, PHCC were equipped with 
a mini-laboratory comprising point-of-care 
The importance of well-planned and implemented task-shifting is highlighted in the literature 
(Kurniasari and Turashvili 2012): 
 Task shifting and inclusion of lower medical cadres in ART provision is one of the most 
important strategies to cope with human resources for health crises in resource-poor 
settings.  
 Countries embarking on public health scale-up of ART with task shifting should include a 
strong training programme for new roles and cadres to ensure successful task shifting. 
The significance of a task-shifting policy according to the literature review (Kurniasari and 
Turashvili 2012): 
 Enabling a country-wide policy environment was key to successful decentralisation and scale-
up.  
 In each country health policies should consider a balance of the local human resource 
capacity and the burden of HIV/TB epidemic in order to ensure equality and access to 
populations.  
 A national policy of task-shifting is a crucial enabling environment for health staff to perform 
quality services. It includes clear job descriptions, training, supportive supervision, 
certification and regular job assessments. 
Decentralisation of HIV/TB care in Shiselweni, Swaziland, summary report, 2013 
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(POC) technology, which could be operated by the trained lay personnel with minimum 
supervisory support18: 
 CD4 point-of-care instrument (PIMA)  
 Biochemistry POC (Reflotron®Plus for tests of creatinine, glucose, potassium and ALAT)  
 Haematology POC (HemoCue 201) 
Improving diagnostics at the regional level included implementation of the Viral load 
testing in the Nhalngano referral laboratory and the first automated analysers for TB 
diagnostics and resistance detection (Xpert®MTB/RIF) in the region. An effective sample 
transportation system from the PHCCs to the reference laboratories provided access and 
timeliness of diagnosis to rural populations.  
More recently the ‘thin layer agar method’ 
was piloted in the Nhlangano TB 
laboratory followed by its consequent 
validation. This method enabled the 
population of the region to access a 
culture of MTB and a drug sensitivity test 
(DST) in significantly shorter time than 
previously.  
 
 
 
2.5 Infection control mechanisms 
Reinforced infection control mechanisms ensured transmission control in the health 
facilities for patients and health workers. The strategy included to improve infrastructure 
at all three levels of health care provision – on secondary health care level in Nhlangano 
health centre, comprising an extremely drug-resistant tuberculosis (XDR-TB) ward, a 
                                                     
18
 (Obregon and Lassovski July 2013) 
Laboratory testing strategies advised in the literature review (Kurniasari and Turashvili 2012): 
 An early initiation of ART based on higher CD4 cell count criteria can be cost-effective in most 
resource-limited settings.  
 Inclusion of viral load in the monitoring process is more effective than CD4 count only. It is 
important to consider a routine access to viral load to support early identification of patients 
who are in need of second- and third-line drugs.  
 A new molecular TB test, Xpert®MTB/RIF, is a marked improvement in TB diagnostic as it 
increases the identification of smear-negative TB, identifies rifampicin resistance and reduces 
the time of investigation. 
  To support decentralised treatment, new simplified and point-of-care tests are needed for 
CD4 count, viral load and TB diagnosis. 
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multidrug-resistant tuberculosis ward (MDR-TB) ward and a TB microbiology laboratory, on 
primary health care level in the clinics of Shiselweni region and on community level in DR-
TB patients’ homes. 
 
2.5.1 Secondary health care level 
The XDR/MDR-TB ward was built nearby the existing Health Centre in Nhlangano. It 
comprises thirteen small or medium sized buildings and is comprised of an inpatient 
department (for 30 patients) and an outpatient department (OPD). A sustainable design 
integrates the exclusive use of natural ventilation (cross-ventilation).  
Infection control is also achieved by organisation of the patient flow according to the risk 
level. A new incinerator is fully operational since the end of 2012 to deal with the increased 
quantity of waste. 
 
2.5.2 Primary health care clinic level 
Numerous infrastructural improvements at clinic level included: building of external 
waiting areas in each of them to accommodate patients outside, building of extra 
consultation rooms adjacent to the clinics equipped with accelerated flow of air from 
outside, construction of Health Care Waste Management (HCWM) etc. 
 
2.5.3 Community level 
In order to decrease DR-TB transmission in the community, it was decided to work with the 
community members on the installation of windows and doors for the improvement of 
ventilation at patients’ homes. This strategy proved to be useful as it allowed a quick 
improvement of the ventilation after the diagnosis of MDR-TB among patients.  
 
2.6 Increased access and universal coverage in Shiselweni 
Decentralisation of activities has greatly increased access to HIV testing and counselling 
serviced (HTC) over the investigated period. The amount of sessions has increased from the 
base-line 17 543 sessions in 2009 up to 40 721 – in 201319 and this way the estimated 
coverage of this service in the region has more than doubled20. 
 
 
                                                     
19
 2013 figure is an estimation based on the first quarter data.  
20
 Assumptions were bases on Shiselweni midyear populations for inhabitants aged > 15 years. Patients on 
ART and estimated to know their HIV status obtained from the 2011 Swaziland HIV Incidence Measurement 
Survey (SHIMS)20 were used to calculate the population eligible for testing. The proportion of patients tested 
(HTC) were calculated and adjusted for new-testers and re-testers.   
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Figure 4 
 
The periphery, including primary health care clinic and community levels, played a decisive 
role catering for more than two-thirds of all HIV testing & counselling sessions performed 
in Shiselweni region.  
Figure 5  
 
The total number of ART initiations in Shiselweni constantly increased from 2008 to 2010 
reaching a ‘universal’ coverage21 in 2012 (vs 17% in 2006). Throughout the period, the 
PHCC took a proportionally bigger burden of the regional case load through 
decentralisation. While new ART initiations in the PHCC level accounted for 54% in 2008, 
they reached 78% in 2012.  
 
 
                                                     
21
 80% of population in ART need on treatment (WHO definition) 
SHCF 
31% 
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Figure 6:  
 
 
2.7 Improved treatment outcomes 
Treatment outcomes of annual ART initiation cohorts have constantly improved over time 
at every follow-up interval. It is impressive that despite the task delegation to lower cadres 
and involvement of lay people in a professional health provision the overall indicators at 
the regional level have improved.  
Figure 7:  
 
 
The ART cohort treatment outcomes at decentralised primary health care clinic level are 
better than at the level of secondary health care facilities. Decentralisation of ART services 
at primary health care clinic level shows successful treatment outcomes despite the 
delegation of new tasks to lower cadres by task shifting and inclusion of lay people and 
PLWHA in the provision of professional health care. These outcomes, in combination with 
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the increased coverage and reaching out to less sick people, show a great success of the 
HIV decentralisation programme in Shiselweni region of Swaziland. 
Huge efforts of decentralisation of TB services in the years 2009 and 2010 have shown their 
effect on the shift of TB treatment initiation: since 2011 more than half of all treatment 
initiations are recorded at primary health care clinics. In general, there is a trend of 
improvement of outcomes for both bacteriologically confirmed and unconfirmed DS-TB 
patients over time at both health care levels. 
 
Figure 8: TB treatment  
 
 
2.8 Wider improvements in public health 
The observed reduction of crude mortality in Shiselweni from 2008 to 2012 may be related 
to the decreasing burden of opportunistic infections (especially TB incidence), which are 
the main reason for morbidity and mortality in populations of the country suffering from a 
high HIV/TB prevalence.  
 
 
 
 
 
Decentralised programme outcomes documented in the literature show similar results: 
 The evidence from various areas supports the general conclusion that good health outcomes 
can be achieved by task shifting to nurses and to lay people.  
 Well-organised task shifting has shown better retention rates in care at decentralised levels.  
 Well-implemented task shifting offers high quality care to more patients than physician-
centred models. 
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Figure 9: Morbidity in Shiselweni region 
 
Figure 10: Crude mortality in Shiselweni region 
 
All aspects mentioned above show that the decentralisation of HIV and TB care in the 
resource-limited setting of Shiselweni increased access to testing and counselling as well as 
TB case findings. It improved treatment outcomes of ART and TB patients and had a wider 
public health impact by reducing overall morbidity and mortality. Decentralised health care 
with task shifting strengthened human resources for health, empowered PLWHA and the 
wider community. Thereby it increased the well-being of the overall society.  
 
2.9 Availability of acceptable and affordable treatment 
Decentralisation has substantially increased the availability22 of and therefore access to 
HIV and TB services. Having services physically accessible at clinics reduced distance and 
transport cost and is highly appreciated by respondents since long distance, travel and time 
                                                     
22
 Availability: physical access, distance, travel time, cost for transport, delay in health service provision, 
limited services e.g. only one ARV consultation day per week; acceptability: cultural access, perceived staff 
attitude, facility cleanliness, waiting time/queues, perceived staff skills, community judgement and stigma; 
affordability: expenses for health care, other costs. Adapted from (Cleary and et al 2012) 
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costs were major barriers for accessing care before decentralisation. However, people 
living in very remote areas still have to cope with access difficulties due to mountainous 
terrain of the region. Affordability for service-costs has shown slight differences between 
different facilities. If small user fees at clinics are not an obstacle for any, higher fees at 
central level or in private clinics (charged for non-ARV/TB care and medicines) still seem to 
deter some patients from the poorer part of the population. Overall the acceptability of 
HIV/TB services at clinic level is very high.  
 
Quality of care is perceived as very good at clinics and as mixed at central facilities. Waiting 
time at clinics is now less than it used to be at central facilities before decentralisation. It 
also significantly decreased overtime at central health facilities. Integration of HIV/TB care 
into primary health care has increased the level of privacy at the clinics. This is not the case 
at central health facilities where HIV care is provided at special ART clinics. There is a 
general agreement that decentralisation and the integration of HIV/TB care into primary 
health care has had a positive impact on the quality of care. Similarly informants agree that 
decentralisation has substantially contributed to increased coverage of early diagnosis and 
treatment, improved treatment outcomes and enabled better retention in HIV care. 
Study participants concluded that the decentralisation of HIV/TB services also positively 
impacted on prevention by improved TB control, prevention of mother-to-child 
transmission services, HIV testing and condom availability.  
Community-based activities were similarly highlighted as a particular strength of the 
Shiselweni model. 
 
2.10 Increased motivation for staff 
The medical professionals at the central level can observe decreased workload compared 
to earlier days of ART and TB treatment provision. Nurses of the clinics differ in their 
perception of the changes in their workload.  
All cadres of health workers feel empowered by successful outcomes of their work after 
decentralisation; their motivation and work satisfaction is very high. Confidence in the 
adequate skills of clinic-staff based on the successful health outcomes of patients was 
expressed not only by the clinic staff, but also by their supervisors from MoH and MSF.  
The literature review highlights the role of decentralisation and task-shifting in improved 
acceptability (Kurniasari and Turashvili 2012): 
 Patients’ perception studies show that despite limited resources the decentralisation of ART 
delivery can improve perceived quality of care, providing a positive impact on HIV infected 
patients’ well-being.  
 Most health workers confirm that task shifting can enhance the quality of patient care. Lay 
counsellors have a deep sense of commitment to their role in health care provision and view 
themselves as professionals providing a critical service.  
 Programmes with well implemented task-shifting also demonstrated better social 
acceptability and contribute to lowered stigma.  
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The skills of the former lay cadres are valued by their professional colleagues and they are 
now seen as specialists in their area e.g. expert clients who work as counsellors are 
perceived as being crucial in their role. Involving people living with HIV/AIDS in health care 
provision is seen as a major key for success of acceptability of HIV testing and treatment, 
adherence and patient empowerment. They encourage disclosure which leads to reduction 
of stigma and are perceived as role-models in the community.  
Interdisciplinary team relationship after decentralisation and integration of HIV/TB 
services accompanied by task shifting is largely perceived as positive, especially at clinic 
level. 
A strong focus on staff health care including infection control measures at the work place, 
as provided by MSF, is highlighted as very important and relevant in this context of high 
HIV prevalence among staff, as is prevention of counsellor burnout.  
 
2.11 Decentralisation is highly cost-effective 
For the health service providers the PHCC approach was weakly dominating the SHC 
approach i.e. that the care given in PHCC was a preferred and advisable approach.  
According to WHO standards, the decentralised antiretroviral (ARV) programme run in 
primary health care clinics in Nhlangano health zone is highly cost-effective from a service 
provider perspective than the one run at the ARV centre in the secondary health care 
facility. This was expressed in the incremental cost-effectiveness ratio (ICER) of $652 per 
life year saved in the PHCC versus SHCF which is much smaller than the gross domestic 
product (GDP) per capita in Swaziland ($5300).23 
According to this approach, intervention in PHCC clinics is highly cost-effective as WHO 
compares the cost-effectiveness ratio of a new intervention with the GDP of a country in  
order to categorize the cost-effectiveness.24  
 
Importantly, inclusion of the costs for patients (patient perspective) in the analysis will 
increase the cost-effectiveness of the PHCC vs SHCF (and decrease the ICER of this study). 
The perception study shows that patients from rural communities saved costs for 
                                                     
23
  (mundi 2013) 
24
 ICER of highly cost-effective intervention is less than GDP per capita; ICER of cost-effective interventions is 
between one and three times GDP per capita; of not cost-effective – more than three times GDP per capita 
(WHO, Choosing interventions that are Cost-effective (WHO-CHOICE): cost-effectiveness thresholds 2013). 
IMPORTANT! 
When it comes to prioritising between different determinants to choose a health facility, 
availability (shorter distance, shorter time and lower cost for travel) seems to be the number one 
determinant for the majority of patients.  
Acceptability issues, e.g. the fear of being recognised by community members at the local clinic 
or the perception of better quality of care at another place, were the reasons for a smaller 
number of patients (from a better-of layer of society) to select a more distant facility. 
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transport, plus saved time for commuting which they could dedicate to an alternative work 
as a result of improved availability of services after the decentralisation to the PHCC.  
However, decentralisation process and task-shifting requires more investment in the 
health of population and is not the means to save money for health care. This is clearly 
indicated in the available literature on the example of task-shifting. 
 
2.11.1 Effective care at primary health care clinic level 
This study shows that the health services provided in the PHC clinics are more effective 
than in the SHCF. The proportion of patients remained on ART after 12 months from their 
enrolment in treatment in PHCC was 88% vs. 76% in the SHCF. This was the result of 
analysis between the two levels of health-facility after adjusting it to the known potential 
confounding factors such as: age, sex and CD4 at the time of ART initiation. There was no 
difference in the proportion of patients who died within 12 months of the initiation at 
these two levels.  
While using a different time line and methodology, the cost-effectiveness study conforms 
to the results of the outcome-analysis study and is reflected in the perceptions of different 
stakeholders as described in the perception study.  
 
2.11.2 Space for cost-saving 
According to the analysis of costs there is a space for cost-saving. The cost of treatment 
(for the service providers) per ART patient a year was slightly higher in PHCC ($311) than in 
SHCF ($233). The main difference is resulting from more human resources for health 
(twice as much cost) in the clinics as compared to the secondary health care facility. This 
hold true for both components of the costs: supervision staff and direct staff costs for 
consultations.  
The analysis of the ratio of consultations per staff shows that higher costs are rather 
related to a lower number of patients coming to the PHCC daily (rather than from staff 
spending too much time with ART patients). Therefore, the same level of quality of care 
could be reached with optimised human resources. 
The lab monitoring cost is almost the same in the two kinds of facilities despite the fact 
that the technology used and the level of cadres performing the tests are very different. 
The transport cost is higher in primary health care clinics but it is not making a big 
difference. 
The literature review about cost-effectiveness and improved access through decentralisation 
and task-shifting: 
 Well-implemented task-shifting offers cost-effective care to more patients than physician-
centred models.  
 Task shifting may allow for a more cost-effective use of clinical resources but it is primarily a 
means of extending access to quality care to a greater number of people. Therefore, task 
shifting should not be considered as a means of simply saving money and will require strong 
government leadership to ensure adequate financing. 
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Optimising the use of human resources for health in the PHCC (direct staff and supervision) 
is therefore a primordial priority for increasing the efficiency of an ARV programme in 
Shiselweni. 
 
2.12 Speed of implementation versus  
engagement of authorities 
Different opinions were expressed about MSF’s high speed of implementing programme 
activities and for its hands-on approach. On the one side, it is perceived that MSF’s rapid 
roll-out of decentralisation has largely benefited patients and contributed to the 
demonstration of the feasibility of new strategies and higher standards of care. Many 
participants concluded that less would have been achieved, if MSF had not played a ‘front 
wheel’ role. On the other hand, MSF was initially perceived by MoH as using an emergency 
approach that was inappropriate for chronic disease control. This perception and the lack 
of joint planning at regional level contributed to initial resistance. It allegedly delayed the 
development of a more productive early collaboration between MoH and MSF. It was, 
however, positively remarked that a shift in MSF’s collaboration with MoH towards much 
more dialogue and integration resulted in a more fruitful partnership. Besides, it seems 
that the impressive results of decentralisation have also made MoH more receptive for 
MSF proposed strategies. Thus, MSF has acted as a catalyser for change not only at field 
but also at policy level. 
 
MSF’s approach of advocating mostly went through the demonstration of feasibility of 
innovations by piloting the new approaches and encouraging operational research. 
Proactive dialogue with the national counterparts and other stakeholders was seen as a 
very powerful tool in identifying priorities and bringing lessons learned across.   
 
2.13 Remaining challenges in Shiselweni and  
future perspectives 
2.13.1 Excluded groups and groups that are hard to reach 
Despite the perceived overall increase in the uptake of testing and treatment services in 
the region, the coverage of these services among men and youths is perceived as low. Low 
The evidence documented in the literature points out the need of finding a balance between 
both approaches (Kurniasari and Turashvili 2012):  
 Early engagement of national authorities in decentralisation and task shifting reinforces local 
leadership and coordination among different actors.  
 Meanwhile, innovative approaches and ‘temporary pilot solutions’ should be thought of for 
immediate alleviation as the legal political changes might take years.  
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diagnostic uptake among men also posed challenges for improved prevention as did an 
inconsistent use of condoms by all groups.  
Paediatric treatment coverage and outcomes are still not satisfactory in the region. Proper 
monitoring and documentation of the PMTCT programmes is also a pending issue.  
 
2.13.2 Stigma 
While stigma and discrimination related to HIV/TB is widely said to have substantially 
reduced over the past years – due to improved knowledge and availability of ART – it is still 
seen as a major barrier for early diagnosis, treatment and retention in HIV care, but also for 
prevention. The fear of stigmatisation and self-stigma hinder disclosure and consequently 
reduce the use of condoms and the uptake of lifelong ARV treatment by pregnant women. 
Community leaders are highly respected and influential. Involving them in all community-
based HIV/TB activities is therefore perceived as a very relevant strategy to increase 
acceptance. 
Whereas differences in gender norms and use of maternity care make it easier to reach 
women at health facilities, expectations on the male gender discourage early health 
seeking behaviour in the modern health sector. This seems to be compounded by men’s 
stronger fear of HIV related stigmatisation and the perceptions of clinics being not male-
friendly enough. Men and youths are seen as groups of society that are hard to reach.  
Traditional medicine remains the first choice and is used in parallel to modern treatment 
by many patients despite increased community knowledge and availability of HIV/TB 
services.  
2.13.3 Sustainability issues 
Despite the fact that some important preconditions for sustainability are met – among 
them the political will to sustain the basic decentralised HIV/TB care model, the capacity 
building of staff and effective laboratory support – great fear is expressed that quality of 
care could drop and some systems could collapse once MSF’s support ended. The major 
barrier for sustainability identified is the lack of funding, namely funding of human 
resources but also for laboratory reagents, sample transport, drug supply and supervision 
that are supported by MSF. MSF’s persisting leadership in the regional programme 
implementation is perceived as another barrier to greater MoH ownership.  
 
2.13.4 Support to secondary health facilities 
MSF’s choice to focus support on clinic level seems to have been justified given the huge 
unmet needs in terms of access to HIV/TB care in the periphery. However, study findings 
suggest that central health facilities have been lacking some support with the consequence 
that they now seem to fall behind the clinics in some aspects.  
Findings from the literature review (Kurniasari and Turashvili 2012): 
 Good preparation and integration with the national systems is important for the successful 
implementation and sustainability of decentralisation.  
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2.13.5 Main problems documented in the literature  
 
2.14 Perspectives of decentralisation and scale-up 
The priorities highlighted for future scale-up of HIV and TB care in Shiselweni include 
 PMTCT B+ followed by the ‘universal treatment’, which among other benefits will offer a 
prevention of new infections,  
 community-based ARV distribution and  
 development of more male-friendly strategies.  
Regarding community-based ARV distribution, doubts were expressed about the suitability 
of ART group models from neighbouring countries. On the policy side, the main priorities 
mentioned comprise the official recognition and implementation of the NTSF, testing 
policies for minors that allow HIV testing without parents’ consent and routine HIV testing 
at health facilities as well as the legalisation of TB home injections by lay CTS.  
 Most of the countries face policy barriers in terms of decentralisation and integration of 
antiretroviral therapy and TB treatment. Delayed or failed adoption of decentralisation 
policies and ineffective task shifting results in overlapped responsibilities and failure to deliver 
quality health care, including HIV/TB care.  
 Practical implementation of the national policies that support HIV/TB integration into other 
health services is equally challenging.  
 The scarcity of human resources for health is the key bottleneck for scaling up and 
decentralising HIV and TB care. 
 The problems related to drug provisions include insufficient supply of drugs (ART and drugs for 
opportunistic infections) and saturation of drug dispensing capacity at health centre level.  
 Unreliability of continued funding has stalled the admission of new patients to treatment and 
put the supply of ARVs at risk in the medium- and long-term in resource-limited countries.  
 Due to the lack of adequate drug formulation options, children continue to be neglected when 
it comes to ART; this is especially tangible in decentralised and resource-poor settings. 
For better organisation of care the literature review suggests the following (Kurniasari and 
Turashvili 2012):  
 It is documented that greater spending on prevention would not only prevent more than half 
of the new infections but would also produce a net financial saving as future costs for 
treatment and care would be averted.  
 Community- and patient-centred approaches as well as improved education of individuals 
and the community increase the demand of HIV services and reduce social barriers to entry 
into care. 
 At each HIV programme stage, effectiveness needs to be improved in order to increase the 
overall outcomes and to improve coverage. Barriers to ART access comprise insufficient 
access to HIV tests, difficulties to refer patients from testing to ART initiation and delays 
between diagnosis and access to HIV care; but also the lack of information about treatment, 
perceived high cost of ART, stigma associated with HIV/AIDS, long distance from home to the 
health facility, lack of coordination across services and the limited involvement of the 
community in the planning process.  
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3 Recommendations 
 
3.1 The Shiselweni project 
1. Address HIV/TB related stigma with the focus on groups that are hard to reach 
 Include community leaders in planning and implementing community-based activities to 
fully exploit their influence on populations for acceptance of services and stigma 
reduction. 
 Encourage disclosure as a vehicle for reduced stigma and discrimination. 
 Strengthen and adapt services for men in their environment and working places. 
• using male staff, male expert clients, male health workers and 
• piloting different opening hours (evenings, weekends). 
 Strengthen youth-friendly (outreach) services.  
 Monitor target groups’ perception and acceptability regularly while piloting new 
male/youth-friendly strategies. 
 
2. Strengthen curative components of the programme 
 Strengthen the early identification and treatment of DR-TB cases as well as their contact 
tracing. 
 
3. Increase cost-effectiveness of the decentralisation programme 
 Reduce supervision costs of the clinics. 
 Reduce costs per consultation visit by optimised staffing. 
 
4. Implement community-based ARV distribution model 
 Establish more decentralised points for regular ARV distribution closer to remote 
communities; schools and Gogo centres could be used for this purpose. 
 Integrate ARVs into mobile clinics. 
 Pilot community ART groups, for example small size ART groups in remote areas. 
 Monitor target groups’ perception and acceptability regularly while piloting different 
community-based ARV distribution models. 
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5. Strengthen MSF support to the regional level and secondary health care facilities in 
Shiselweni  
 Strengthen support to the regional health authorities in terms of their management 
capacity and supervision to primary health care clinics. 
 Strengthen support to the secondary health care facilities of Shiselweni in clinical ART 
management and task-shifting, integration of TB and HIV services. 
 
6. Increase sustainability of the current Shiselweni HIV/TB programme 
 Empower regional MoH counterparts by training in management and coordination. 
 Ensure systematic joint programme planning, monitoring and supervision activities etc. 
to foster MoH ownership and allow long-term preparation for handover of programme 
components. 
 Explore alternative funding possibilities and identify implementing agencies to take over 
components currently supported by MSF. 
 Systematically assess the workload of the clinics compared to international/national 
standards to optimise the amount of staff. 
 
7. Address policy issues 
 Advocate for full implementation of the National Task-Shifting Framework. 
 Develop an updated HIV testing policy for minors that will increase access to HIV testing 
for them.  
 Advocate for an acceptable and feasible solution to ensure community-based MDR-TB 
treatment.  
 
3.2 Swaziland country level 
Replicate the best practice components of HIV/TB decentralisation in Shiselweni at 
national level 
 Nurse-led ART and TB at all health facilities and well-organised task-shifting to new 
cadres 
 Strong patient support, education and counselling by expert clients 
 Strong HIV and TB integration into general health care and a relevant focus on (MDR) TB  
 Strong community component, ensuring link between health facilities and community 
 Decentralisation of laboratory by mini-laboratories for all clinics and sample 
transportation system to reference laboratories  
 Piloting of innovations and operational research 
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3.3 Contexts with high HIV/TB co-infections and limited 
resources 
 
3.4 Long-term MSF HIV/TB programmes worldwide 
Invest in more cooperative implementation of HIV/TB programmes  
 Invest in bottom-up, joint programme planning with counterparts in the context of  
longer-term programmes. 
 Find the right time to shift from a (rapid) MSF implementing approach to a more 
sustainable approach with stronger MoH ownership. 
 Ensure supervision and monitoring systems of high efficiency jointly with the MoH.  
Documented literature suggests to actively promote decentralisation of HIV/AIDS and TB care 
in high prevalence settings with limited resources as a successful strategy (Kurniasari and 
Turashvili 2012): 
 Ensure a supportive regulatory environment for decentralisation and task-shifting: 
coordination and consultation with different regulatory and executive bodies. 
 Address shortages of human resources for health by 
• building health care providers’ capacity by improved human resources recruitment and 
retention, task-shifting, training and supportive supervision, implementation of simplified 
and standardised treatment approaches and by 
• strengthening the district health management capacity. 
 Strengthen the focus on preventive activities while increasing enrolment and retention in 
curative chain of care. 
 Invest in paediatric treatment: improve drug availability and access to ART in resource-poor 
settings. 
 Expand access to essential drugs as a part of strengthened primary health care. The 
saturation of drug dispensing at health centre level could be addressed by involving 
communities in dispensing ART. 
 Ensure enough finances for further scale-up of ART:  
• Continue lobbying for fulfilling commitments by the donor organisations.  
• Reduce dependency on donors by mobilising internal resources and ensuring affordable 
generic versions of drugs. 
 Address stigma and include infected people in health care provision for further roll-out of 
HIV and TB programmes. 
 Ensure adequate infrastructure to boost health care givers’ motivation and increase 
community confidence in decentralised care. 
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4 Annex 
 
4.1 Terms of reference 
Terms of reference for evaluation of the decentralisation strategy for 
HIV/TB care in Shiselweni, Swaziland 
 
Commissioned by Cell 1 MSF-CH 
Duration of evaluation 12 months  
Time period that is evaluated from 2008 year to 2012 year 
 
ToR elaborated by Coordination team Mbabane + Cell1 MSF-CH + MedDep + 
Vienna Evaluation Unit 
 
1. CONTEXT 
The Kingdom of Swaziland is a southern African country, which shares borders with the Republic of South 
Africa on the north, west and south and with the Republic of Mozambique on the east. The country extends 
over a landmass of 17, 364 square kilometres. Swaziland is considered the smallest country in the southern 
hemisphere. 
Swaziland is one of the three remaining monarchies in Africa, and the only monarchy where the King wields 
executive power. 
Despite being perceived to be having a reasonable resource base compared to many developing countries, 
the majority of people (80%) in the country live below the poverty threshold (income of E 128.6 per month or 
equivalent of $ 0.7 per day) and the level of unemployment is around 45%. 
In line with the economic growth, the health situation of the Swazi population had improved significantly 
during the eighties and early nineties.  However, as the HIV/AIDS and TB epidemics escalated, all these health 
gains were reversed: The population growth rate is now stagnant (if not in decline). It was estimated at 2% in 
2005 compared to 2.8% in 1997 and 3.2% in 1986. 
Prior to the demographic impact of the AIDS epidemic, the quality of life of people living in the country had 
improved significantly from a life expectancy at birth of 44 years in 1966 to 60 years by 1997 with females (63 
years) living slightly longer than males (58 years). Current life expectancy at birth is estimated at an average 
of 39 years, which is at present one of the lowest estimate of life expectancy worldwide. It is estimated that 
there are 182’792 people HIV positive in SD today. 
Swaziland is currently faced with dramatic HIV/AIDS and Tuberculosis (TB) epidemics threatening the 
existence of present and future generations of Swazi people. 26% of young adults (15-49 yrs) are infected 
with HIV and will die in the years to come if not treated with ARV. Despite the existing capacity to respond 
with health care and “impact mitigation”, Swaziland risks to become one of the first examples of countries 
where this “dual” HIV/AIDS-TB epidemic “overwhelms” the existing capacity and destabilizes its population. 
HIV/AIDS 
Antenatal care sentinel surveillance has recorded a ten-fold increase of the HIV prevalence level among 
pregnant mothers in only 12 years, from 3.9 % in 1992 up to 42.8 % in 2004 and slightly decreasing down to 
39.2 % in 2006, but back up at 42% and 41% in 2008 and 2010 respectively. Similar trends of HIV sero-
prevalence among antenatal care attendants are recorded in the four regions; in urban as well as rural areas.  
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The most accurate estimates on HIV prevalence levels were provided by the findings of the 2006/07 
Swaziland Demographic and Health Survey (SDHS) which had included a population based survey on HIV 
prevalence in people > 2 years old from a sample of 5,500 households25:  
These updated and more accurate estimates of the HIV prevalence levels are lower than the ones provided 
by the antenatal care sentinel surveillance.  Still, Swaziland remains the country with the highest prevalence 
levels of HIV infection when compared with the findings of similar population based surveys in the most 
affected countries in sub-Saharan Africa26. 
The SDHS confirmed very high levels of awareness among women as well as men at reproductive age but still 
insufficient use of condoms and low attendance of HIV testing and counseling services especially among men; 
36 % of the surveyed women knew their HIV status from a recent HIV test compared with only 17 % of the 
surveyed men, with even a bigger difference in the rural areas. 
Only in recent years has this advanced HIV epidemic started to show its full dramatic impact on health, 
survival and the socio-economic development of the Swazi society. 
Hospitals are overcrowded with 80 % of hospital admissions due to HIV/AIDS and TB.  
 Annual TB notification increased from 210/100,000 to 820 per 100,000 between 1990 and 2004, reaching 
1’155/100’000 in 2009, the highest TB case notification rate in the world.  
 AIDS/TB related deaths among adults and children are overtaking other causes of death; at present 
estimated at 16,000 per year (close to 1.4 % of the Swaziland population).  The World Bank projects that 
by 2015 AIDS related deaths will reach about 22,000 per year, ten to eleven times more than the 
projected 2,000 non-AIDS related deaths.   
 The Swazi population is projected to increase only up to 1,58 million by 2015, which is 41 % below the 
expectation in the absence of AIDS. 
 A study by the 3 Ministries of Finance, Economic Planning and Public Service projects that close to 32 % of 
staff will be lost in 20 years due to AIDS. 
 A recent study on subsistence agriculture showed significant decline in area under cultivation at 
household level, decline of crop yield, diversion of labour to care for the sick, increase in health costs and 
loss of income. 
Tuberculosis 
Linked to the catastrophic HIV/AIDS epidemic, Swaziland has been facing a dramatic six-fold increase of TB 
case notification in the last 15 years. TB notification and the estimated TB incidence rates are now the highest 
in the world (ahead of Djibouti and South Africa).  
DR TB is a consistent threat to the country’s population and more specifically the HIV+ population, an 
indication supported by the results of the DST survey conducted in Sd in 2009-2010. It is established thet 
more 7.7% of all new TB cases are MDR TB cases and that 33.4% of retreated cases are also MDR TB cases. 
This prevalence level puts SD in the league of most affected countries worldwide.  
Health care services 
Swaziland has 6 general hospitals (of which 2 are faith-based), one psychiatric hospital in Manzini city and 
one DR TB hospital outside Manzini, which started be operational in January 2009. The 6 general hospitals 
have integrated services for TB diagnosis and treatment; HIV testing and counselling; prevention of mother to 
child transmission of HIV (PMTCT); HIV care and ARV treatment (since early 2003) as well as extensive but 
often “overloaded” hospitalization capacity (200–450 beds).  
 
                                                     
25
 82 % coverage for HIV testing among people at reproductive age (15-49 years) surveyed.  
26
 Ranking according to HIV prevalence level in the reproductive age group: Swaziland (26 %) followed by 
Botswana (24 %), Lesotho (24 %), Zimbabwe (18 %), South Africa (16 %), Zambia (16 %) and Malawi (12 %). 
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There are also five governmental health centres, which are small hospitals with a hospitalization capacity of 
between 30 and 50 beds, laboratory facilities and occasionally X-ray facilities. These 5 health centres have 
also integrated services for TB diagnosis and treatment; HIV testing and counselling; PMTCT; HIV care and 
ARV treatment (as of 2005). The small inpatient wards of these health centres are often overcrowded with 
patients with opportunistic infections due to HIV/AIDS. 
More than 177 clinics exist in the country and they are either government (public), mission, NGOs, private or 
industry based.  All these clinics offer primary health care services; most of these have integrated HIV testing 
and counselling but mainly limited to access for pregnant mothers for basic PMTCT services. WHO option A is 
presently the preferred option for SD. 
The management of the PHC clinics is under the regional health departments. The hospitals and the health 
centres are managed jointly by the respective facility Matron and the Senior Medical Officer. At the region 
level there is the Regional Health Management Team (RHMT) composed of the regional matron, facility 
matrons, SMOs, the Regional TB Coordinators and few other key staffs. The RHMT is chaired by the Regional 
Health Administrator.  
The public health units of the respective hospitals and health centres also organise outreach activities to 
outreach or community sites (187) of which some belong to the 345 “neighbourhood care points” (NCPs) set 
up with the help of UNICEF and the National Emergency Response Council on HIV/AIDS (NERCHA). 
In this context, the “added value” of MSF to the HIV and TB response in Swaziland is our operational 
capacity to: 
 Push forward decentralisation of HIV and TB services up to the level of clinics and community with 
promotion through implementation of “one stop TB/HIV point of care”  
 Improve management of DR TB including demonstration of better approaches for treatment delivery at 
community level through treatment supporters. 
 Introduce new diagnostic and treatment practices in the country, as well as advocating for new public 
health approaches, such as Treatment as Prevention  
 Mobilise and involve people with HIV/AIDS at all levels. 
 Organise formal treatment education and support to treatment adherence.  
 Strengthen supervision and support increased capacity as well as quality of HIV and TB services at referral 
centres level as well as clinics.  
 “Network” with non-governmental actors at national and regional level, associations of activists and 
community support groups.  
 Lobby and advocate for the rights of people with HIV and/or TB and their dependents; for an increase of 
humanitarian assistance; for equity in access to HIV/TB testing, care and treatment; for access to essential 
medicines and diagnostics; and for access to human resources 
 
2. OVERALL OBJECTIVE and PURPOSE 
Main objective is to evaluate a decentralised model of care of HIV/AIDS & TB in the region of Shiselweni, 
Swaziland in terms of its effectiveness and efficiency (Cost-effectiveness).   
Purpose of this evaluation is to evaluate quantitative and qualitative aspects of the decentralised model of 
care for HIV/AIDS &TB patients in Shishelweni region during 2008  Q2 of 2012 in order to:  
1. capitalise the experience within MSF in order to inform similar projects elsewhere  
2. share the experience with MSF partners in Swaziland and possibly (if successful) promote its replication in 
the country  
3. Share the experience (shared MSF/MoH) widely through publication/s 
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3. KEY EVALUATION QUESTIONS 
1. Describe the decentralization model used in Shiselweni project.  What was the role of the Human 
Resources adjustment and task shifting in the decentralisation in Shiselweni? Describe these in terms of:   
 National Task-Shifting Framework 
 Introduction of new cadre to the primary health clinic team (pharmacy assistants, phlebotomists, 
expert clients) 
 Completion of the PHC team (additional nurses) 
 Introduction of new tasks to the PHC team (initiation of TB and ART, NARTIS), CTS 
2. Describe the role of Infrastructural and Logistic inputs to the decentralization in Shiselweni:  
 Renovations/rehabilitations in PHCs (sputum cabinets, waiting areas, drug storage room, minilabs) 
 TB ward 
 Infection control measures/waste management 
 Transportation of samples to regional laboratories 
 Shipment of sputum samples to supranational laboratories 
3. Describe the role of New technologies/approaches to the decentralization in Shiselweni:  
 Point-of-care CD4s 
 Point of care biochemistry tests 
 Rapid diagnostic tests in PHCs 
 Flourescence microscopy 
 Xpert®MTB/RIF 
 Thin layer agar 
 Viral load testing/EID 
  TB injections at home…as approach?  
4. Which quality of care (including access to care) was achieved according to the quantitative indicators: on 
outcome (quantity of HIV and/or TB patients detected and enrolled, IPT, cure, referred, defaulters, 
retention in care, deaths for both diseases; success rates and relapses for TB treatment, number of DRTB 
patients) and output (VCT uptake, average CD4 upon HIV diagnosis and initiation of ART, % of AB 
prophylaxis, time to ART, time to TB treatment, % of OI)? Comparison to be done: 
  According to the time line 
 According to the level: Hospital, Health centre, clinic, community or home based 
 Stratify according to gender, age, initial staging, place of origin… 
 Stratify according to HIV or TB alone, or co-infections, PMTCT…… 
What were problems, consequences and solutions? How much scale up was possible?  
5. What is the perception of quality of care and level of acceptability of the stake holders (authorities, 
medical staff, patients and community) of the HIV/TB decentralised model of care in Shiselweni? 
 On access/feasibility (e.g. saved time and money) 
 On acceptability (e.g. satisfaction with care, closeness to the community, reasons for defaulting etc.) 
 On successes and failures (continuity of care, impact on other health care providers etc.) 
 Change in stigma 
What were problems to scaling-up? Consequences and solutions? Future perspectives? 
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6. How do resources and costs compare to the outcomes in the centralised and decentralised approaches? 
A perspective of the health care-provider will be adopted:  
 Calculating and comparing costs per Patient/year at the central and decentralised level 
  Costs shall include HR (Training and supervision), drugs and supply.  
 
4. EXPECTED RESULTS and INTENTED USE OF THE EVALUATION 
 Documentation of a decentralised model of care 
 Quantitative and qualitative study comparing centralised and decentralised approach. 
 Description and evaluation of task shifting 
 Description of advantage and disadvantages of the decentralised model of care components. 
 Lessons learned and traps to avoid 
 Recommendations for improvement of the decentralization model used in Shiselweni 
 Documentation for advocacy at national, regional and international level.  
 Material for the production of protocols, guidelines or tools.  
 Information for the conception and preparation of the Test and Treat strategy 
 Identification of additional research questions if applicable. 
 Documents produced:  
 Evaluation report internal to MSF 
 Evaluation report for the MoH and other external partners 
 Presentation in GVA for the cell, medical and ops departments. 
 
5. PRACTICAL IMPLEMENTATION OF THE EVALUATION 
Literature research is on-going. 
Field visit of the evaluators’ team is on 1st of October (Coordination team to confirm that all 4 evaluators can 
come together).  
Perception and task-shifting: See: Study Protocol for ERB and ToR on Perception.  
Purposeful sampling of the clinics will be used to collect and analyse primary data: Interveiw with staff, 
beneficiaries and other stakeholders, observation.  
Cost-effectiveness – See the ToR 
Retrospective Epidemiological analysis: will include possibly all clinics and mother facilities. Methodology to 
be designed once an epidemiologist is identified. 
 
6. TOOLS AND METHODOLOGY PROPOSED (if any) 
 Literature research on decentralisation strategies for HIV/TB (including particularly on task shifting) 
 Review of reports and other relevant project-related documents   
 Briefings and individual interviews with key people at MSF HQ, coordination, field (medical staff, 
community workers…) 
 Meetings and interviews with key actors at MoH central and regional level, other counterparts 
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 Group Interviews and focus group discussions (e.g. community workers, expert patients, patients and 
community members) 
 Review of data base and individual medical files (MSF and MoH data) from the purposefully sampled 
clinics where decentralisation took place.  
 Analysis of the data from the data-monitoring system.  
 Random sampling of medical records (includes framing of the patient-groups, random sampling, 
identifying and collecting data and analysing) - might be considered.  
 Review of records (lab, pharmacy, opd….) and supply orders 
 Observation of medical practices  
 Identification, measuring and costing of resources and outputs/effects  
 
7. DOCUMENTATION FOR READING 
 Annual reports covering the period 2008  2011 
 Decentralisation intermediate report 2008-2010 
 
8. JOB PROFILE/S of EVALUATOR/S 
Coordinator of the overall evaluation – Mzia Turashvili Evaluation unit 
Literature review – a consultant (Miladi Kurniasari) 
The perception study – a researcher on a general perception (Heidi Becher) and a researcher focused on task-   
shifting (Sarah Lachat), national researchers 
An epidemiologist – Bernhard Kerschberger 
Health economist – a consultant (Guillaume Jouquet) 
Technical reports on laboratory and logistics: people from the field (lab technician and logistic coordinator)  
Others as required 
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4.3 List of interviewees 
Ministry of Health and National Government 
1.  Dr Okello VELEPHI (female) SNAP (Swazi National ART programme) coordinator 
2.  Nompilo GWEBU (female) SNAP expert clients national coordinator 
3.  Sharon NIEVES (female) NERCHA regional coordinator Shiselweni 
4.  Matron MANAANA (male) Shiselweni regional HIV coordinator 
5.  Nomthandazo MAPHALALA  Health zone supervisor of patient support, education and 
counselling unit 
6.  Sister Pureen MADHLOPA 
(female) 
Shiselweni zone supervisor - Hlatikhulu 
7.  Dr Shabango DLAMINI (male) Hospital director, senior medical officer - Hlatikulu hospital 
8.  Dr Munyaradzi Pasipamire 
(male) 
ART clinic doctor - Hlatikulu hospital 
9.  Mr Themba (male) TB national programme director 
  
MSF 
 
10.  Aymeric PEGUILLAN (male) Former head of mission Swaziland 
11.  Josephine MASIKINI (male) Former task shifting officer Swaziland  
12.  Dr Hermann REUTER (male) Former medical doctor Swaziland  
13.  Dr Andrej SLAWUCKIJ (male) Former programme manager, Cell 1 
14.  Dr Micaela SERAFINI (female) Medical reference, Cell 1 
15.  Annette RAVAUD (female) Referent nursing PSEC and health promotion 
16.  Aude THOREL (female) Former human resources officer, Cell 1 
17.  Fred MANSON (male) Human resources officer, Cell 1 
18.  Elias PAVLOPULOS (male) Head of mission 
19.  Dr Hayk KARAKOZIAN (male) Medical coordinator 
20.  Dr Bernhard KERSHBERGER 
(male) 
Deputy medical coordinator  
21.  Gilberto SAMPASA (male) Human resources coordinator  
22.  Yannick JULLIOT (male) Logistic coordinator 
23.  Joanne CYR (female) PSEC advisor 
24.  Peterjan WOODA (male) Field coordinator  
25.  Dr Calorine MEKIEDJE (female) HIV/TB coordinator 
26.  Dr Dodho MUNYARADZI (male) Medical doctor 
27.  Beatrice VAZQUEZ (female) TB coordinator 
28.  Maryvonne LECOQ LASSOVSKI 
(female) 
Laboratory supervisor 
29.  Tengentile HLOPE (female) Regional PSEC coordinator 
30.  Oliver KIER (male) Deputy field coordinator, health zone Nhlangano 
31.  Trine MAROTT (female) Deputy field coordinator, health zone Matsanjeni 
32.  Nkanyiso GAMBU (male) Nurse supervisor, Hlatikulu health zone 
33.  Fexon NCUBE (male) Nurse supervisor, Matsanjeni health zone 
34.  Mxolisi DLAMINI (male) TB psychosocial officer  
35.  Bekuzulu Khumalo (male) Esther 
Kuveya, (female) 
Pharmacy supervisors, Hlatikulu and Nhlangano zone  
(group of 2 people) 
  
Partners 
 
36.  Alisson END (female) CHAI, country director 
37.  Peter PREKO (male) CDC/PEPFAR, former ICAP 
38.  Dr KEFAS (male) WHO, medical officer responsible for TB 
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39.  Victoria MASUKU (female) PSI,HIV system strengthening director 
40.  Dr Pilard USTERO (female) Baylor College of Medicine Children's Foundation Swaziland 
– Texas Baylor College of Medicine 
41.  Mnedezi ZWANE (male) Swannepha, regional coordinator, Shiselweni 
42.  Sipiwe HLOPE (female) Swapol, director 
43.  Cebile DLAMINI (female) Swapol, programme coordinator 
44.  Keus KEES (male) MSF OCA, project coordinator 
45.  Dr Mahdi (male) EGPAF, country director 
 
Community expert clients (EC) and CTS 
46.  Community EC in Lamuvisa (male) 
47.  Community EC in Mahlandle (female) 
48.  Community EC in Mashobeni (female) 
49.  Community EC in Nkwene (female) 
50.  Community EC in Olos (female) 
51.  Community EC in Nhletsheni (2 people, Female and Male) 
52.  Community treatment supporter in Mashobeni (female) 
 
Community leaders  
53.  Community leader 1 in Mashobeni (male) 
54.  Community leader 2 in Mashobeni  (male) 
55.  Community leader in Induna Matsanjeni (male) 
56.  Community leader in Induna Nkwene (male) 
57.  Community leader in Mahlandle (male) 
58.  Community leader in Nhletsheni (male) 
59.  Community leader in Bukhopo Matsanjeni (female) 
60.  Community leader in Olos (group of two, both male)  
 
M2M counsellors 
61.  M2M counsellor in Mashobeni (female) 
62.  M2M supervisor in Mahlandle (female) 
 
Expert clients 
63.  EC in Hlatikuku, TB clinic , was interviewed with a CTC , (both male) 
64.  EC in Lamuvisa (female) 
65.  EC in Mahlandle (female) 
66.  EC in Mashobeni (female) 
67.  EC in Nhletsheni (female) 
68.  EC in Nkwene (female) 
69.  EC in Olos (female) 
 
HTC 
70.  HTC ART clinic in Hlathikulu (male) 
71.  HTC MSF mobile HIV testing team  in Nhlangano (female) 
 
Nurses MoH 
72.  Nurse MoH in Lavumisa, (female) 
73.  Nurse MoH in Hlathikhulu, (female) 
74.  Nurse MoH in Mashobeni, (male) 
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75.  Nurse MoH in Nhletshini, (female) 
76.  Nurse Senior MoH in Olos, (female) 
77.  Nurse Senior MoH in Mahlandle, (male) 
78.  Nurse Senior MoH in Nhletsheni, (male) 
 
Nurses MSF 
79.  Nurse MSF in Lavumisa, (female) 
80.  Nurse MSF in Hlathikhulu, (female) 
81.  Nurse MSF in Nkwene, (female) 
 
Pastors  
82.  Pastor in Olos (female) 
83.  Pastor in New Haven (male) 
 
Patients  
84.  Patient 1 in Hlathikhulu, ART clinic (female) 
85.  Patient 2 in Hlathikhulu, ART clinic (male) 
86.  Patient in Lavumisa (female) 
87.  Patient  1 in Malhendle (male) 
88.  Patient 2 in Malhendle (male) 
89.  Patient 3 in Malhendle (female) 
90.  Patient 1 in Mashobeni (female) 
91.  Patient 2 in Mashobeni (male) 
92.  Patient 1 in Nhletcheni (female) 
93.  Patient 2 in Nhletcheni (female) 
94.  Patient 1 in Olos (female) 
95.  Patient 2 in Olos, (female) 
96.  Patient 1 in Nkwene (male) 
97.  Patient 2 in Nkwene (female) 
98.  Patient 3 in Nkwene (female) 
 
Pharmacy assistants 
99.  Pharmacy  assitant in Nkwene, (female) 
100. Pharmacy assistant in Nhletcheni,(female) 
 
Phlebotomists 
101. Phlebotomist in Mahlandle, (female) 
102. Phlebotomist in Nhletsheni, (male) 
103. Phlebotomist in Nkwene, (male) 
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104. Phlebotomist in Olos, (female) 
105. Phlebotomist in Lavumisa, (female) 
 
Rural health motivators 
106. Rural health motivator in Nkwene, (female) 
107. Rural health motivators in Matsanjeni (group of 2 women) 
 
Traditional healers  
108. Traditional healer in Mahlandle, (female) 
109. Traditional healer in Matsanjeni and her husband, (group of 2 people) 
110. Traditional healer in Nkwene, (female) 
 
Focus groups  
111. Expert client (EC) from non-selected clinic 
(all female) 
9 (clinic and community ECs) 
112. MDR TB patients in Hlathikhulu (both 
genders) 
5  
113. Nurses in Nhlangano Clinics (Females) 4 (2 MSF, 2 MoH) 
114. Patient support group in Nkwene (male) 4 
115. Patient support group in Matsanjeni (both 
genders),  
7 
116. Patient support group in Nhletsheni (both 
genders),  
11 
117. Patient support group in Nkwene (female) 6 
118. Pharmacy assistants (both genders )  6 
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